The university began clinical trials of the vaccine produced by Russia' s Gamalei Institute of Epidemiology and Microbiology on June 18.
According to Alexander Lukashev, a director at Sechenov University, the objective of this stage of the study was to show the vaccine's safety for human health, which was successfully done.
Information about when this vaccine will enter the commercialisation stage is awaited.
Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told Russian news agency TASS on Sunday that the human trials for the vaccine have been completed at the university and the volunteers will be discharged soon.
The first stage of Thai clinical trials will enrol about 100 volunteers separated into two groups, one for people aged 18 to 60 and the other for 60- to 80-year-olds, Kiat said.
Non-human primates which received a second dose of the vaccine displayed high levels of COVID-19 antibodies, which the research team called an encouraging sign in light of the upcoming human trials scheduled in October, the team said.
In the meantime, the volunteers have been kept in single or double wards on campus at Sechenov University.
NFL’s Washington to drop Redskins nickname on Monday
The decision comes 11 days after naming-rights sponsor FedEx's public statement asking for a change to the controversial moniker. This despite the name coming under increased scrutiny in recent years as being racist and demeaning toward Native Americans.
After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days.
They will likely be given two shots and will be monitored for a year in order for scientists to assess the success rate.
If all goes well with the vaccine in the next phases and it is approved for use, Gintsburg said that "about 50-60 million doses of the vaccine, or maybe even 70 million, will need to be produced in order to carry out mass coronavirus vaccination in Russian Federation".
When expectations were running high that it would be China, where the novel coronavirus had its origin in the city of Wuhan, unexpectedly Russian Federation has announced first to the world that its clinical trials are completed successfully and the vaccine is ready for production.
Sinovac Biotech has reported positive preliminary data from the Phase 1 and 2 clinical trials of its COVID-19 vaccine candidate, CoronaVac.
Queensland has recorded no new cases of coronavirus in the past 24 hours. The British drugmaker has started conducting pPase 3 human trials of its AZD1222 (formerly known as ChAdOx1 nCoV-19) vaccine candidate.